$ENOV
Enovis CORP

2022 Q2 Form 10-Q Financial Statement

#000142080022000008 Filed on May 10, 2022

View on sec.gov

Income Statement

Concept 2022 Q2 2021 Q2
Revenue $1.023B $879.2M
YoY Change 16.4% 7.7%
Cost Of Revenue $593.1M $508.1M
YoY Change 16.73% 8.54%
Gross Profit $430.2M $371.1M
YoY Change 15.94% 6.57%
Gross Profit Margin 42.04% 42.21%
Selling, General & Admin $369.4M $305.7M
YoY Change 20.82% 4.63%
% of Gross Profit 85.86% 82.39%
Research & Development $24.40M $19.90M
YoY Change 22.61% 7.57%
% of Gross Profit 5.67% 5.36%
Depreciation & Amortization $66.03M $62.79M
YoY Change 5.16% 7.63%
% of Gross Profit 15.35% 16.92%
Operating Expenses $393.8M $325.6M
YoY Change 20.93% 4.8%
Operating Profit $53.12M $61.31M
YoY Change -13.36% 30.89%
Interest Expense $15.10M $25.66M
YoY Change -41.16% 3.48%
% of Operating Profit 28.43% 41.85%
Other Income/Expense, Net
YoY Change
Pretax Income $38.02M $35.65M
YoY Change 6.65% 61.73%
Income Tax $18.70M $7.900M
% Of Pretax Income 49.19% 22.16%
Net Earnings $16.30M $20.24M
YoY Change -19.46% 267.47%
Net Earnings / Revenue 1.59% 2.3%
Basic Earnings Per Share $0.28 $0.41
Diluted Earnings Per Share $0.28 $0.40
COMMON SHARES
Basic Shares Outstanding 53.87M shares 46.53M shares
Diluted Shares Outstanding 54.41M shares 47.26M shares

Balance Sheet

Concept 2022 Q2 2021 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments $661.5M $763.7M
YoY Change -13.38%
Cash & Equivalents $661.5M $763.7M
Short-Term Investments
Other Short-Term Assets $91.55M $79.11M
YoY Change 15.72% -48.94%
Inventory $852.8M $606.2M
Prepaid Expenses $84.82M $75.21M
Receivables $657.1M $553.8M
Other Receivables $0.00 $0.00
Total Short-Term Assets $2.348B $2.078B
YoY Change 12.98% 31.38%
LONG-TERM ASSETS
Property, Plant & Equipment $504.6M $479.2M
YoY Change 5.29% 2.35%
Goodwill $3.441B $3.332B
YoY Change 3.27% 4.39%
Intangibles $1.637B $1.653B
YoY Change -0.95% 0.28%
Long-Term Investments
YoY Change
Other Assets $374.8M $354.3M
YoY Change 5.79% -9.64%
Total Long-Term Assets $6.136B $5.989B
YoY Change 2.46% 1.95%
TOTAL ASSETS
Total Short-Term Assets $2.348B $2.078B
Total Long-Term Assets $6.136B $5.989B
Total Assets $8.484B $8.067B
YoY Change 5.17% 8.2%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $537.7M $406.7M
YoY Change 32.19% 10.53%
Accrued Expenses $490.1M $424.3M
YoY Change 15.5% 0.02%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due $422.3M $727.4M
YoY Change -41.94% 2605.48%
Total Short-Term Liabilities $1.450B $1.558B
YoY Change -6.96% 90.26%
LONG-TERM LIABILITIES
Long-Term Debt $1.648B $1.482B
YoY Change 11.19% -41.03%
Other Long-Term Liabilities $601.0M $597.8M
YoY Change 0.54% -8.05%
Total Long-Term Liabilities $2.249B $2.080B
YoY Change 8.13% -34.25%
TOTAL LIABILITIES
Total Short-Term Liabilities $1.450B $1.558B
Total Long-Term Liabilities $2.249B $2.080B
Total Liabilities $3.840B $3.776B
YoY Change 1.7% -8.31%
SHAREHOLDERS EQUITY
Retained Earnings $604.1M $536.4M
YoY Change 12.61% 11.94%
Common Stock $54.00K $135.0K
YoY Change -60.0% 14.41%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $4.600B $4.247B
YoY Change
Total Liabilities & Shareholders Equity $8.484B $8.067B
YoY Change 5.17% 8.2%

Cashflow Statement

Concept 2022 Q2 2021 Q2
OPERATING ACTIVITIES
Net Income $16.30M $20.24M
YoY Change -19.46% 267.47%
Depreciation, Depletion And Amortization $66.03M $62.79M
YoY Change 5.16% 7.63%
Cash From Operating Activities -$14.42M $84.38M
YoY Change -117.09% 50.07%
INVESTING ACTIVITIES
Capital Expenditures $24.09M $24.54M
YoY Change -1.83% -21.14%
Acquisitions $13.82M $103.5M
YoY Change -86.64% 1221.52%
Other Investing Activities -$11.08M -$103.5M
YoY Change -89.29%
Cash From Investing Activities -$35.17M -$128.0M
YoY Change -72.53% 243.61%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -$10.82M $707.7M
YoY Change -101.53% 188.68%
NET CHANGE
Cash From Operating Activities -$14.42M $84.38M
Cash From Investing Activities -$35.17M -$128.0M
Cash From Financing Activities -$10.82M $707.7M
Net Change In Cash -$57.87M $662.6M
YoY Change -108.73% 158.85%
FREE CASH FLOW
Cash From Operating Activities -$14.42M $84.38M
Capital Expenditures $24.09M $24.54M
Free Cash Flow -$38.51M $59.85M
YoY Change -164.35% 138.27%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2022Q2 dei Entity Central Index Key
EntityCentralIndexKey
0001420800
CY2022Q2 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2022Q2 dei Amendment Flag
AmendmentFlag
false
CY2022Q2 dei Entity Registrant Name
EntityRegistrantName
Enovis CORP
CY2022Q2 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q1
CY2022Q2 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2022
CY2022Q2 dei Document Type
DocumentType
10-Q
CY2022Q2 dei Document Quarterly Report
DocumentQuarterlyReport
true
CY2022Q2 dei Document Period End Date
DocumentPeriodEndDate
2022-04-01
CY2022Q2 dei Document Transition Report
DocumentTransitionReport
false
CY2022Q2 dei Entity File Number
EntityFileNumber
001-34045
CY2022Q2 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
CY2022Q2 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
54-1887631
CY2022Q2 dei Entity Address Address Line1
EntityAddressAddressLine1
2711 Centerville Road,
CY2022Q2 dei Entity Address Address Line2
EntityAddressAddressLine2
Suite 400
CY2022Q2 dei Entity Address City Or Town
EntityAddressCityOrTown
Wilmington,
CY2022Q2 dei Entity Address State Or Province
EntityAddressStateOrProvince
DE
CY2022Q2 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
19808
CY2022Q2 dei City Area Code
CityAreaCode
(302)
CY2022Q2 dei Local Phone Number
LocalPhoneNumber
252-9160
CY2022Q2 dei Security12b Title
Security12bTitle
Common Stock, par value $0.001 per share
CY2022Q2 dei Trading Symbol
TradingSymbol
ENOV
CY2022Q2 dei Security Exchange Name
SecurityExchangeName
NYSE
CY2022Q2 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2022Q2 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2022Q2 dei Entity Filer Category
EntityFilerCategory
Large Accelerated Filer
CY2022Q2 dei Entity Small Business
EntitySmallBusiness
false
CY2022Q2 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
CY2022Q2 dei Entity Shell Company
EntityShellCompany
false
CY2022Q2 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
54030880 shares
CY2022Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
1023368000 USD
CY2021Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
879211000 USD
CY2022Q2 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
593137000 USD
CY2021Q2 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
508134000 USD
CY2022Q2 us-gaap Gross Profit
GrossProfit
430231000 USD
CY2021Q2 us-gaap Gross Profit
GrossProfit
371077000 USD
CY2022Q2 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
369390000 USD
CY2021Q2 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
305724000 USD
CY2022Q2 us-gaap Restructuring Charges
RestructuringCharges
7723000 USD
CY2021Q2 us-gaap Restructuring Charges
RestructuringCharges
4046000 USD
CY2022Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
53118000 USD
CY2021Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
61307000 USD
CY2022Q2 us-gaap Interest Expense
InterestExpense
15099000 USD
CY2021Q2 us-gaap Interest Expense
InterestExpense
25660000 USD
CY2022Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
38019000 USD
CY2021Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
35647000 USD
CY2022Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
18660000 USD
CY2021Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
7917000 USD
CY2022Q2 us-gaap Income Loss From Continuing Operations
IncomeLossFromContinuingOperations
19359000 USD
CY2021Q2 us-gaap Income Loss From Continuing Operations
IncomeLossFromContinuingOperations
27730000 USD
CY2022Q2 us-gaap Income Loss From Discontinued Operations Net Of Tax
IncomeLossFromDiscontinuedOperationsNetOfTax
-3058000 USD
CY2021Q2 us-gaap Income Loss From Discontinued Operations Net Of Tax
IncomeLossFromDiscontinuedOperationsNetOfTax
-7490000 USD
CY2022Q2 us-gaap Profit Loss
ProfitLoss
16301000 USD
CY2021Q2 us-gaap Profit Loss
ProfitLoss
20240000 USD
CY2021Q2 us-gaap Profit Loss
ProfitLoss
20240000 USD
CY2022Q2 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
1233000 USD
CY2021Q2 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
1166000 USD
CY2022Q2 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
15068000 USD
CY2021Q2 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
19074000 USD
CY2022Q2 us-gaap Income Loss From Continuing Operations Per Basic Share
IncomeLossFromContinuingOperationsPerBasicShare
0.34
CY2021Q2 us-gaap Income Loss From Continuing Operations Per Basic Share
IncomeLossFromContinuingOperationsPerBasicShare
0.57
CY2022Q2 us-gaap Discontinued Operation Income Loss From Discontinued Operation Net Of Tax Per Basic Share
DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerBasicShare
-0.06
CY2021Q2 us-gaap Discontinued Operation Income Loss From Discontinued Operation Net Of Tax Per Basic Share
DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerBasicShare
-0.16
CY2022Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.28
CY2021Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.41
CY2022Q2 us-gaap Income Loss From Continuing Operations Per Diluted Share
IncomeLossFromContinuingOperationsPerDilutedShare
0.33
CY2021Q2 us-gaap Income Loss From Continuing Operations Per Diluted Share
IncomeLossFromContinuingOperationsPerDilutedShare
0.56
CY2022Q2 us-gaap Discontinued Operation Income Loss From Discontinued Operation Net Of Tax Per Diluted Share
DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerDilutedShare
-0.06
CY2021Q2 us-gaap Discontinued Operation Income Loss From Discontinued Operation Net Of Tax Per Diluted Share
DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerDilutedShare
-0.16
CY2022Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.28
CY2021Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.40
CY2022Q2 us-gaap Profit Loss
ProfitLoss
16301000 USD
CY2021Q2 us-gaap Profit Loss
ProfitLoss
20240000 USD
CY2022Q2 us-gaap Other Comprehensive Income Loss Foreign Currency Translation Adjustment Tax
OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax
338000 USD
CY2021Q2 us-gaap Other Comprehensive Income Loss Foreign Currency Translation Adjustment Tax
OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax
2280000 USD
CY2022Q2 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-53461000 USD
CY2021Q2 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-53181000 USD
CY2022Q2 us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss Before Reclassification Tax
OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationTax
2711000 USD
CY2021Q2 us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss Before Reclassification Tax
OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationTax
4243000 USD
CY2022Q2 us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss Before Reclassification After Tax
OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax
9028000 USD
CY2021Q2 us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss Before Reclassification After Tax
OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax
12381000 USD
CY2022Q2 us-gaap Other Comprehensive Income Loss Reclassification Adjustment From Aoci Pension And Other Postretirement Benefit Plans For Net Gain Loss Tax
OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossTax
199000 USD
CY2021Q2 us-gaap Other Comprehensive Income Loss Reclassification Adjustment From Aoci Pension And Other Postretirement Benefit Plans For Net Gain Loss Tax
OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossTax
317000 USD
CY2022Q2 us-gaap Other Comprehensive Income Loss Reclassification Adjustment From Aoci Pension And Other Postretirement Benefit Plans For Net Gain Loss Net Of Tax
OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossNetOfTax
-629000 USD
CY2021Q2 us-gaap Other Comprehensive Income Loss Reclassification Adjustment From Aoci Pension And Other Postretirement Benefit Plans For Net Gain Loss Net Of Tax
OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossNetOfTax
-1055000 USD
CY2022Q2 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-43804000 USD
CY2021Q2 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-39745000 USD
CY2022Q2 us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
-27503000 USD
CY2021Q2 us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
-19505000 USD
CY2022Q2 us-gaap Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
895000 USD
CY2021Q2 us-gaap Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
1042000 USD
CY2022Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-28398000 USD
CY2021Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-20547000 USD
CY2022Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
661504000 USD
CY2021Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
719370000 USD
CY2022Q2 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
37871000 USD
CY2021Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
32501000 USD
CY2022Q2 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
657056000 USD
CY2021Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
638700000 USD
CY2022Q2 us-gaap Inventory Net
InventoryNet
852814000 USD
CY2021Q4 us-gaap Inventory Net
InventoryNet
776295000 USD
CY2022Q2 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
84816000 USD
CY2021Q4 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
78186000 USD
CY2022Q2 us-gaap Other Assets Current
OtherAssetsCurrent
91547000 USD
CY2021Q4 us-gaap Other Assets Current
OtherAssetsCurrent
90728000 USD
CY2022Q2 us-gaap Assets Current
AssetsCurrent
2347737000 USD
CY2021Q4 us-gaap Assets Current
AssetsCurrent
2303279000 USD
CY2022Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
504583000 USD
CY2021Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
521391000 USD
CY2022Q2 us-gaap Goodwill
Goodwill
3440615000 USD
CY2021Q4 us-gaap Goodwill
Goodwill
3467295000 USD
CY2022Q2 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
1637257000 USD
CY2021Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
1675462000 USD
CY2022Q2 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
178643000 USD
CY2021Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
184429000 USD
CY2022Q2 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
374816000 USD
CY2021Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
363489000 USD
CY2022Q2 us-gaap Assets
Assets
8483651000 USD
CY2021Q4 us-gaap Assets
Assets
8515345000 USD
CY2022Q2 us-gaap Long Term Debt Current
LongTermDebtCurrent
422289000 USD
CY2021Q4 us-gaap Long Term Debt Current
LongTermDebtCurrent
8314000 USD
CY2021Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
606323000 USD
CY2022Q2 us-gaap Liabilities
Liabilities
3839606000 USD
CY2022Q2 us-gaap Accounts Payable Current
AccountsPayableCurrent
537676000 USD
CY2021Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
504173000 USD
CY2022Q2 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
490050000 USD
CY2021Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
511097000 USD
CY2022Q2 us-gaap Liabilities Current
LiabilitiesCurrent
1450015000 USD
CY2021Q4 us-gaap Liabilities Current
LiabilitiesCurrent
1023584000 USD
CY2022Q2 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
1647870000 USD
CY2021Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
2078679000 USD
CY2022Q2 cfx Operating Lease Liability Present Value Noncurrent
OperatingLeaseLiabilityPresentValueNoncurrent
140704000 USD
CY2021Q4 cfx Operating Lease Liability Present Value Noncurrent
OperatingLeaseLiabilityPresentValueNoncurrent
145326000 USD
CY2022Q2 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
601017000 USD
CY2021Q4 us-gaap Liabilities
Liabilities
3853912000 USD
CY2022Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2021Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2021Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
133333333 shares
CY2022Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
133333333 shares
CY2022Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
54030880 shares
CY2022Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
54030880 shares
CY2021Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
52083078 shares
CY2021Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
52083078 shares
CY2022Q2 us-gaap Common Stock Value
CommonStockValue
54000 USD
CY2021Q4 us-gaap Common Stock Value
CommonStockValue
52000 USD
CY2022Q2 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
4555369000 USD
CY2021Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
4544315000 USD
CY2022Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
604092000 USD
CY2021Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
589024000 USD
CY2022Q2 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-559479000 USD
CY2021Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-516013000 USD
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
4600036000 USD
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
4617378000 USD
CY2022Q2 us-gaap Minority Interest
MinorityInterest
44009000 USD
CY2021Q4 us-gaap Minority Interest
MinorityInterest
44055000 USD
CY2022Q2 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
4644045000 USD
CY2021Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
4661433000 USD
CY2022Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
8483651000 USD
CY2021Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
8515345000 USD
CY2021Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
4661433000 USD
CY2022Q2 us-gaap Profit Loss
ProfitLoss
16301000 USD
CY2022Q2 us-gaap Minority Interest Decrease From Distributions To Noncontrolling Interest Holders
MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders
941000 USD
CY2022Q2 us-gaap Other Comprehensive Income Loss Tax
OtherComprehensiveIncomeLossTax
3248000 USD
CY2022Q2 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-43804000 USD
CY2022Q2 us-gaap Stock Issued During Period Shares Conversion Of Units
StockIssuedDuringPeriodSharesConversionOfUnits
1691845 shares
CY2022Q2 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
11056000 USD
CY2022Q2 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
4644045000 USD
CY2020Q4 us-gaap Shares Outstanding
SharesOutstanding
39498896 shares
CY2020Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
3587874000 USD
CY2021Q2 us-gaap Profit Loss
ProfitLoss
20240000 USD
CY2021Q2 us-gaap Minority Interest Decrease From Distributions To Noncontrolling Interest Holders
MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders
1054000 USD
CY2021Q2 us-gaap Other Comprehensive Income Loss Tax
OtherComprehensiveIncomeLossTax
6840000 USD
CY2021Q2 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-39745000 USD
CY2021Q2 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
711321000 USD
CY2021Q2 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
12433000 USD
CY2021Q2 us-gaap Shares Outstanding
SharesOutstanding
45199110 shares
CY2021Q2 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
4291069000 USD
CY2022Q2 us-gaap Profit Loss
ProfitLoss
16301000 USD
CY2021Q2 us-gaap Profit Loss
ProfitLoss
20240000 USD
CY2022Q2 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
66026000 USD
CY2021Q2 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
62785000 USD
CY2022Q2 us-gaap Share Based Compensation
ShareBasedCompensation
9857000 USD
CY2021Q2 us-gaap Share Based Compensation
ShareBasedCompensation
7807000 USD
CY2022Q2 cfx Noncashinterestexpense
Noncashinterestexpense
978000 USD
CY2022Q2 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
70830000 USD
CY2021Q2 cfx Noncashinterestexpense
Noncashinterestexpense
1537000 USD
CY2022Q2 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
2232000 USD
CY2021Q2 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-3614000 USD
CY2022Q2 us-gaap Gain Loss On Sale Of Properties
GainLossOnSaleOfProperties
-352000 USD
CY2021Q2 us-gaap Gain Loss On Sale Of Properties
GainLossOnSaleOfProperties
-257000 USD
CY2022Q2 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
20690000 USD
CY2021Q2 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
39950000 USD
CY2021Q2 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
32743000 USD
CY2022Q2 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
24713000 USD
CY2021Q2 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
83442000 USD
CY2022Q2 us-gaap Increase Decrease In Other Operating Capital Net
IncreaseDecreaseInOtherOperatingCapitalNet
43362000 USD
CY2021Q2 us-gaap Increase Decrease In Other Operating Capital Net
IncreaseDecreaseInOtherOperatingCapitalNet
15379000 USD
CY2022Q2 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-14423000 USD
CY2021Q2 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
84382000 USD
CY2022Q2 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
24089000 USD
CY2022Q2 us-gaap Proceeds From Lines Of Credit
ProceedsFromLinesOfCredit
0 USD
CY2021Q2 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
24537000 USD
CY2022Q2 us-gaap Proceeds From Sale Of Buildings
ProceedsFromSaleOfBuildings
2746000 USD
CY2021Q2 us-gaap Proceeds From Sale Of Buildings
ProceedsFromSaleOfBuildings
0 USD
CY2022Q2 us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
13823000 USD
CY2021Q2 us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
103475000 USD
CY2022Q2 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-35166000 USD
CY2021Q2 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-128012000 USD
CY2021Q2 us-gaap Proceeds From Lines Of Credit
ProceedsFromLinesOfCredit
179367000 USD
CY2022Q2 us-gaap Repayments Of Lines Of Credit
RepaymentsOfLinesOfCredit
7428000 USD
CY2021Q2 us-gaap Repayments Of Lines Of Credit
RepaymentsOfLinesOfCredit
185643000 USD
CY2022Q2 us-gaap Proceeds From Issuance Or Sale Of Equity
ProceedsFromIssuanceOrSaleOfEquity
1199000 USD
CY2021Q2 us-gaap Proceeds From Issuance Or Sale Of Equity
ProceedsFromIssuanceOrSaleOfEquity
716632000 USD
CY2022Q2 us-gaap Proceeds From Payments For Other Financing Activities
ProceedsFromPaymentsForOtherFinancingActivities
-4590000 USD
CY2021Q2 us-gaap Proceeds From Payments For Other Financing Activities
ProceedsFromPaymentsForOtherFinancingActivities
-2704000 USD
CY2022Q2 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-10819000 USD
CY2021Q2 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
707652000 USD
CY2022Q2 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
2542000 USD
CY2021Q2 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
-1438000 USD
CY2022Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-57866000 USD
CY2021Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
662584000 USD
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
719370000 USD
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
101069000 USD
CY2022Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
661504000 USD
CY2021Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
763653000 USD
CY2022Q2 us-gaap Number Of Operating Segments
NumberOfOperatingSegments
2 segment
CY2022Q2 us-gaap Use Of Estimates
UseOfEstimates
The Company makes certain estimates and assumptions in preparing its Condensed Consolidated Financial Statements in accordance with GAAP. These estimates and assumptions affect the reported amounts of assets and liabilities, the disclosure of contingent assets and liabilities as of the date of the Condensed Consolidated Financial Statements, and the reported amounts of revenues and expenses for the periods presented. Actual results may differ from those estimates.In the normal course of business, the Company incurs research and development costs related to new product development which are expensed as incurred and included in Selling, general and administrative expense on the Company’s Condensed Consolidated Statements of Operations. Research and development costs were $24.4 million and $19.9 million during the three months ended April 1, 2022 and April 2, 2021, respectively.
CY2022Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
24400000 USD
CY2021Q2 us-gaap Cash Provided By Used In Operating Activities Discontinued Operations
CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations
7300000 USD
CY2021Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
19900000 USD
CY2022Q2 cfx Disposal Group Including Discontinued Operations Asbestos Related Costs Net Of Tax
DisposalGroupIncludingDiscontinuedOperationsAsbestosRelatedCostsNetOfTax
2500000 USD
CY2021Q2 cfx Disposal Group Including Discontinued Operations Asbestos Related Costs Net Of Tax
DisposalGroupIncludingDiscontinuedOperationsAsbestosRelatedCostsNetOfTax
900000 USD
CY2022Q2 us-gaap Cash Provided By Used In Operating Activities Discontinued Operations
CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations
5800000 USD
CY2022Q2 cfx Payments To Acquire Investments And Asset Acquisitions
PaymentsToAcquireInvestmentsAndAssetAcquisitions
13800000 USD
CY2022Q2 cfx Numberof Sales Channels
NumberofSalesChannels
3 salesChannel
CY2021Q4 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
31500000 USD
CY2020Q4 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
36600000 USD
CY2022Q2 us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
12800000 USD
CY2021Q2 us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
14300000 USD
CY2022Q2 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
31400000 USD
CY2021Q2 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
40000000 USD
CY2022Q2 cfx Contractwith Customer Liability One Time Advance Payments
ContractwithCustomerLiabilityOneTimeAdvancePayments
2000000 USD
CY2021Q4 cfx Contractwith Customer Liability One Time Advance Payments
ContractwithCustomerLiabilityOneTimeAdvancePayments
4900000 USD
CY2021Q4 us-gaap Financing Receivable Allowance For Credit Losses
FinancingReceivableAllowanceForCreditLosses
32501000 USD
CY2022Q2 us-gaap Provision For Loan Losses Expensed
ProvisionForLoanLossesExpensed
5206000 USD
CY2022Q2 us-gaap Financing Receivable Allowance For Credit Losses Write Offs
FinancingReceivableAllowanceForCreditLossesWriteOffs
141000 USD
CY2022Q2 cfx Financing Receivable Allowancefor Credit Loss Foreign Currency Translation1
FinancingReceivableAllowanceforCreditLossForeignCurrencyTranslation1
23000 USD
CY2022Q2 us-gaap Financing Receivable Allowance For Credit Losses
FinancingReceivableAllowanceForCreditLosses
37871000 USD
CY2022Q2 cfx Net Incomefromcontinuingoperationsattributableto Parent
NetIncomefromcontinuingoperationsattributabletoParent
18126000 USD
CY2021Q2 cfx Net Incomefromcontinuingoperationsattributableto Parent
NetIncomefromcontinuingoperationsattributabletoParent
26564000 USD
CY2022Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
53872007 shares
CY2021Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
46534463 shares
CY2022Q2 us-gaap Income Loss From Continuing Operations Per Basic Share
IncomeLossFromContinuingOperationsPerBasicShare
0.34
CY2021Q2 us-gaap Income Loss From Continuing Operations Per Basic Share
IncomeLossFromContinuingOperationsPerBasicShare
0.57
CY2022Q2 cfx Net Incomefromcontinuingoperationsattributableto Parent
NetIncomefromcontinuingoperationsattributabletoParent
18126000 USD
CY2021Q2 cfx Net Incomefromcontinuingoperationsattributableto Parent
NetIncomefromcontinuingoperationsattributabletoParent
26564000 USD
CY2022Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
53872007 shares
CY2021Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
46534463 shares
CY2022Q2 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
536967 shares
CY2021Q2 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
722639 shares
CY2022Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
54408974 shares
CY2021Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
47257102 shares
CY2022Q2 us-gaap Income Loss From Continuing Operations Per Diluted Share
IncomeLossFromContinuingOperationsPerDilutedShare
0.33
CY2021Q2 us-gaap Income Loss From Continuing Operations Per Diluted Share
IncomeLossFromContinuingOperationsPerDilutedShare
0.56
CY2021Q2 us-gaap Income Loss From Continuing Operations Attributable To Noncontrolling Entity
IncomeLossFromContinuingOperationsAttributableToNoncontrollingEntity
1200000 USD
CY2022Q2 us-gaap Income Loss From Continuing Operations Attributable To Noncontrolling Entity
IncomeLossFromContinuingOperationsAttributableToNoncontrollingEntity
1200000 USD
CY2022Q2 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
500000 shares
CY2022Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
38000000 USD
CY2022Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
18700000 USD
CY2022Q2 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.491 Rate
CY2021Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
35600000 USD
CY2021Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
7900000 USD
CY2021Q2 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.222 Rate
CY2022Q2 us-gaap Stock Repurchase Program Authorized Amount1
StockRepurchaseProgramAuthorizedAmount1
100000000 USD
CY2022Q2 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
-37863000 USD
CY2022Q2 cfx Other Comprehensive Income Loss Intra Entity Foreign Currency Translation Adjustment Adjustments Net Of Tax
OtherComprehensiveIncomeLossIntraEntityForeignCurrencyTranslationAdjustmentAdjustmentsNetOfTax
-15260000 USD
CY2022Q2 us-gaap Translation Adjustment For Net Investment Hedge Increase Decrease Net Of Tax
TranslationAdjustmentForNetInvestmentHedgeIncreaseDecreaseNetOfTax
9028000 USD
CY2022Q2 us-gaap Other Comprehensive Income Loss Before Reclassifications Net Of Tax
OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax
-44095000 USD
CY2022Q2 us-gaap Reclassification From Accumulated Other Comprehensive Income Current Period Net Of Tax
ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
-629000 USD
CY2022Q2 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-43466000 USD
CY2021Q2 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
-84155000 USD
CY2021Q2 cfx Other Comprehensive Income Loss Intra Entity Foreign Currency Translation Adjustment Adjustments Net Of Tax
OtherComprehensiveIncomeLossIntraEntityForeignCurrencyTranslationAdjustmentAdjustmentsNetOfTax
31098000 USD
CY2021Q2 us-gaap Translation Adjustment For Net Investment Hedge Increase Decrease Net Of Tax
TranslationAdjustmentForNetInvestmentHedgeIncreaseDecreaseNetOfTax
12381000 USD
CY2021Q2 us-gaap Other Comprehensive Income Loss Before Reclassifications Net Of Tax
OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax
-40676000 USD
CY2021Q2 us-gaap Reclassification From Accumulated Other Comprehensive Income Current Period Net Of Tax
ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
-1055000 USD
CY2021Q2 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-39621000 USD
CY2019Q1 cfx Tangible Equity Units Issued Amount
TangibleEquityUnitsIssuedAmount
4600000 USD
CY2019Q1 cfx Tangible Equity Units Issued Par Value
TangibleEquityUnitsIssuedParValue
100
CY2019Q1 cfx Tangible Equity Units Issued Cash Proceeds
TangibleEquityUnitsIssuedCashProceeds
447700000 USD
CY2019Q1 cfx Tangible Equity Units Allocated To Equity Percentage
TangibleEquityUnitsAllocatedToEquityPercentage
0.844
CY2019Q1 cfx Tangible Equity Units Allocated To Debt Percentage
TangibleEquityUnitsAllocatedToDebtPercentage
0.156
CY2022Q1 cfx Stock Purchase Contracts Converted
StockPurchaseContractsConverted
100000 shares
CY2022Q2 us-gaap Conversion Of Stock Shares Converted1
ConversionOfStockSharesConverted1
1700000 shares
CY2021Q2 us-gaap Conversion Of Stock Shares Converted1
ConversionOfStockSharesConverted1
100000 shares
CY2019Q1 cfx Tangible Equity Units Issued Amount
TangibleEquityUnitsIssuedAmount
4600000 USD
CY2022Q2 cfx Tangible Equity Units Threshold For Conversion
TangibleEquityUnitsThresholdForConversion
6100000 shares
CY2022Q2 us-gaap Inventory Raw Materials
InventoryRawMaterials
233031000 USD
CY2021Q4 us-gaap Inventory Raw Materials
InventoryRawMaterials
215200000 USD
CY2022Q2 us-gaap Inventory Work In Process
InventoryWorkInProcess
76208000 USD
CY2021Q4 us-gaap Inventory Work In Process
InventoryWorkInProcess
69101000 USD
CY2022Q2 us-gaap Inventory Finished Goods
InventoryFinishedGoods
626911000 USD
CY2021Q4 us-gaap Inventory Finished Goods
InventoryFinishedGoods
567281000 USD
CY2022Q2 us-gaap Inventory Gross
InventoryGross
936150000 USD
CY2021Q4 us-gaap Inventory Gross
InventoryGross
851582000 USD
CY2022Q2 us-gaap Inventory Lifo Reserve
InventoryLIFOReserve
-797000 USD
CY2021Q4 us-gaap Inventory Lifo Reserve
InventoryLIFOReserve
-1129000 USD
CY2022Q2 us-gaap Inventory Valuation Reserves
InventoryValuationReserves
84133000 USD
CY2021Q4 us-gaap Inventory Valuation Reserves
InventoryValuationReserves
76416000 USD
CY2022Q2 us-gaap Inventory Net
InventoryNet
852814000 USD
CY2021Q4 us-gaap Inventory Net
InventoryNet
776295000 USD
CY2022Q2 cfx Lifo Inventory Percentage
LIFOInventoryPercentage
0.174
CY2021Q4 cfx Lifo Inventory Percentage
LIFOInventoryPercentage
0.183
CY2022Q2 us-gaap Long Term Debt
LongTermDebt
2070159000 USD
CY2021Q4 us-gaap Long Term Debt
LongTermDebt
2086993000 USD
CY2022Q2 cfx Tangible Equity Unit Initial Principal Amount
TangibleEquityUnitInitialPrincipalAmount
15.6099
CY2022Q2 us-gaap Long Term Debt Current
LongTermDebtCurrent
422289000 USD
CY2021Q4 us-gaap Long Term Debt Current
LongTermDebtCurrent
8314000 USD
CY2022Q2 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
1647870000 USD
CY2021Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
2078679000 USD
CY2022Q2 cfx Long Term Debt Reclassed To Current Maturities
LongTermDebtReclassedToCurrentMaturities
421300000 USD
CY2022Q2 us-gaap Debt Weighted Average Interest Rate
DebtWeightedAverageInterestRate
0.0174
CY2022Q2 us-gaap Line Of Credit Facility Remaining Borrowing Capacity
LineOfCreditFacilityRemainingBorrowingCapacity
375000000 USD
CY2022Q2 cfx Interest Rateof Tangible Equity Notes
InterestRateofTangibleEquityNotes
0.0650
CY2022Q2 cfx Tangible Equity Unit Quarterly Cash Distribution
TangibleEquityUnitQuarterlyCashDistribution
1.4375
CY2022Q2 cfx Tangible Equity Unit Repayment
TangibleEquityUnitRepayment
6500000 USD
CY2021Q2 cfx Tangible Equity Unit Repayment
TangibleEquityUnitRepayment
6100000 USD
CY2022Q2 us-gaap Letters Of Credit Outstanding Amount
LettersOfCreditOutstandingAmount
40200000 USD
CY2022Q2 us-gaap Debt Instrument Unamortized Discount
DebtInstrumentUnamortizedDiscount
11300000 USD
CY2022Q2 cfx Customeradvancesandbillinginexcessofcostsincurred
Customeradvancesandbillinginexcessofcostsincurred
31440000 USD
CY2021Q4 cfx Customeradvancesandbillinginexcessofcostsincurred
Customeradvancesandbillinginexcessofcostsincurred
31468000 USD
CY2022Q2 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
39939000 USD
CY2022Q2 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
122172000 USD
CY2021Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
142203000 USD
CY2022Q2 us-gaap Accrued Income Taxes Current
AccruedIncomeTaxesCurrent
70152000 USD
CY2021Q4 us-gaap Accrued Income Taxes Current
AccruedIncomeTaxesCurrent
72276000 USD
CY2022Q2 cfx Accrued Asbestos Liability
AccruedAsbestosLiability
34494000 USD
CY2021Q4 cfx Accrued Asbestos Liability
AccruedAsbestosLiability
30572000 USD
CY2022Q2 us-gaap Product Warranty Accrual Classified Current
ProductWarrantyAccrualClassifiedCurrent
19331000 USD
CY2021Q4 us-gaap Product Warranty Accrual Classified Current
ProductWarrantyAccrualClassifiedCurrent
17457000 USD
CY2022Q2 us-gaap Restructuring Reserve Current
RestructuringReserveCurrent
9546000 USD
CY2021Q4 us-gaap Restructuring Reserve Current
RestructuringReserveCurrent
10221000 USD
CY2022Q2 us-gaap Accrued Sales Commission Current
AccruedSalesCommissionCurrent
34119000 USD
CY2021Q4 us-gaap Accrued Sales Commission Current
AccruedSalesCommissionCurrent
38492000 USD
CY2021Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
42403000 USD
CY2022Q2 us-gaap Interest Payable Current And Noncurrent
InterestPayableCurrentAndNoncurrent
9586000 USD
CY2021Q4 us-gaap Interest Payable Current And Noncurrent
InterestPayableCurrentAndNoncurrent
11065000 USD
CY2022Q2 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
119271000 USD
CY2021Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
114940000 USD
CY2022Q2 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
490050000 USD
CY2021Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
511097000 USD
CY2021Q4 us-gaap Product Warranty Accrual
ProductWarrantyAccrual
17457000 USD
CY2020Q4 us-gaap Product Warranty Accrual
ProductWarrantyAccrual
15543000 USD
CY2022Q2 us-gaap Product Warranty Accrual Warranties Issued
ProductWarrantyAccrualWarrantiesIssued
2129000 USD
CY2021Q2 us-gaap Product Warranty Accrual Warranties Issued
ProductWarrantyAccrualWarrantiesIssued
2042000 USD
CY2022Q2 us-gaap Product Warranty Accrual Preexisting Increase Decrease
ProductWarrantyAccrualPreexistingIncreaseDecrease
836000 USD
CY2021Q2 us-gaap Product Warranty Accrual Preexisting Increase Decrease
ProductWarrantyAccrualPreexistingIncreaseDecrease
589000 USD
CY2022Q2 us-gaap Product Warranty Accrual Payments
ProductWarrantyAccrualPayments
1112000 USD
CY2021Q2 us-gaap Product Warranty Accrual Payments
ProductWarrantyAccrualPayments
2472000 USD
CY2022Q2 us-gaap Product Warranty Accrual Additions From Business Acquisition
ProductWarrantyAccrualAdditionsFromBusinessAcquisition
0 USD
CY2021Q2 us-gaap Product Warranty Accrual Additions From Business Acquisition
ProductWarrantyAccrualAdditionsFromBusinessAcquisition
321000 USD
CY2022Q2 us-gaap Standard And Extended Product Warranty Accrual Foreign Currency Translation Gain Loss
StandardAndExtendedProductWarrantyAccrualForeignCurrencyTranslationGainLoss
21000 USD
CY2021Q2 us-gaap Standard And Extended Product Warranty Accrual Foreign Currency Translation Gain Loss
StandardAndExtendedProductWarrantyAccrualForeignCurrencyTranslationGainLoss
-224000 USD
CY2022Q2 us-gaap Product Warranty Accrual
ProductWarrantyAccrual
19331000 USD
CY2021Q2 us-gaap Product Warranty Accrual
ProductWarrantyAccrual
15799000 USD
CY2021Q4 us-gaap Restructuring Reserve
RestructuringReserve
10937000 USD
CY2022Q2 cfx Restructuring Settlementand Impairment Provisionsbeforenoncashcharges
RestructuringSettlementandImpairmentProvisionsbeforenoncashcharges
7938000 USD
CY2022Q2 us-gaap Payments For Restructuring
PaymentsForRestructuring
9137000 USD
CY2022Q2 us-gaap Restructuring Reserve Translation Adjustment
RestructuringReserveTranslationAdjustment
-36000 USD
CY2022Q2 us-gaap Restructuring Reserve
RestructuringReserve
9702000 USD
CY2022Q2 cfx Noncashimpairmentrestructuringprovisions
Noncashimpairmentrestructuringprovisions
319000 USD
CY2022Q2 us-gaap Restructuring Settlement And Impairment Provisions
RestructuringSettlementAndImpairmentProvisions
8257000 USD
CY2021Q2 us-gaap Long Term Debt Fair Value
LongTermDebtFairValue
2100000000 USD
CY2022Q2 us-gaap Long Term Debt Fair Value
LongTermDebtFairValue
2100000000 USD
CY2022Q2 us-gaap Cash And Cash Equivalents Fair Value Disclosure
CashAndCashEquivalentsFairValueDisclosure
5875000 USD
CY2022Q2 us-gaap Deferred Compensation Plan Assets
DeferredCompensationPlanAssets
13811000 USD
CY2022Q2 us-gaap Assets Fair Value Disclosure
AssetsFairValueDisclosure
21314000 USD
CY2022Q2 us-gaap Deferred Compensation Liability Current And Noncurrent
DeferredCompensationLiabilityCurrentAndNoncurrent
13811000 USD
CY2022Q2 us-gaap Liabilities Fair Value Disclosure
LiabilitiesFairValueDisclosure
16795000 USD
CY2021Q4 us-gaap Cash And Cash Equivalents Fair Value Disclosure
CashAndCashEquivalentsFairValueDisclosure
8133000 USD
CY2021Q4 us-gaap Deferred Compensation Plan Assets
DeferredCompensationPlanAssets
11213000 USD
CY2021Q4 us-gaap Assets Fair Value Disclosure
AssetsFairValueDisclosure
21953000 USD
CY2021Q4 us-gaap Deferred Compensation Liability Current And Noncurrent
DeferredCompensationLiabilityCurrentAndNoncurrent
11213000 USD
CY2021Q4 us-gaap Liabilities Fair Value Disclosure
LiabilitiesFairValueDisclosure
14257000 USD
CY2022Q2 us-gaap Derivative Asset Notional Amount
DerivativeAssetNotionalAmount
203600000 USD
CY2021Q4 us-gaap Derivative Asset Notional Amount
DerivativeAssetNotionalAmount
273200000 USD
CY2021Q4 us-gaap Loss Contingency Pending Claims Number
LossContingencyPendingClaimsNumber
14559
CY2020Q4 us-gaap Loss Contingency Pending Claims Number
LossContingencyPendingClaimsNumber
14809
CY2022Q2 us-gaap Loss Contingency New Claims Filed Number
LossContingencyNewClaimsFiledNumber
1065
CY2021Q2 us-gaap Loss Contingency New Claims Filed Number
LossContingencyNewClaimsFiledNumber
1067
CY2022Q2 us-gaap Loss Contingency Claims Settled And Dismissed Number
LossContingencyClaimsSettledAndDismissedNumber
779
CY2021Q2 us-gaap Loss Contingency Claims Settled And Dismissed Number
LossContingencyClaimsSettledAndDismissedNumber
581
CY2022Q2 us-gaap Loss Contingency Pending Claims Number
LossContingencyPendingClaimsNumber
14845
CY2021Q2 us-gaap Loss Contingency Pending Claims Number
LossContingencyPendingClaimsNumber
15295
CY2022Q2 cfx Asbestos Insurance Asset Noncurrent
AsbestosInsuranceAssetNoncurrent
229215000 USD
CY2021Q4 cfx Asbestos Insurance Asset Noncurrent
AsbestosInsuranceAssetNoncurrent
231900000 USD
CY2022Q2 cfx Insurance Receivable Asbestos Noncurrent
InsuranceReceivableAsbestosNoncurrent
17002000 USD
CY2021Q4 cfx Insurance Receivable Asbestos Noncurrent
InsuranceReceivableAsbestosNoncurrent
15421000 USD
CY2022Q2 cfx Accrued Asbestos Liability
AccruedAsbestosLiability
34494000 USD
CY2021Q4 cfx Accrued Asbestos Liability
AccruedAsbestosLiability
30572000 USD
CY2022Q2 cfx Asbestos Liability Noncurrent
AsbestosLiabilityNoncurrent
254106000 USD
CY2021Q4 cfx Asbestos Liability Noncurrent
AsbestosLiabilityNoncurrent
261779000 USD
CY2022Q2 us-gaap Number Of Operating Segments
NumberOfOperatingSegments
2 segment
CY2022Q2 us-gaap Revenues
Revenues
1023368000 USD
CY2021Q2 us-gaap Revenues
Revenues
879211000 USD
CY2022Q2 cfx Segment Operating Income
SegmentOperatingIncome
64002000 USD
CY2021Q2 cfx Segment Operating Income
SegmentOperatingIncome
67106000 USD
CY2022Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
38019000 USD
CY2021Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
35647000 USD
CY2022Q2 us-gaap Interest Expense
InterestExpense
15099000 USD
CY2021Q2 us-gaap Interest Expense
InterestExpense
25660000 USD
CY2022Q2 cfx Restructuring Chargesand Other Related Charges
RestructuringChargesandOtherRelatedCharges
8257000 USD
CY2021Q2 cfx Restructuring Chargesand Other Related Charges
RestructuringChargesandOtherRelatedCharges
4046000 USD
CY2022Q2 cfx Medical Device Regulation Costs
MedicalDeviceRegulationCosts
2627000 USD
CY2021Q2 cfx Medical Device Regulation Costs
MedicalDeviceRegulationCosts
1753000 USD
CY2022Q2 cfx Segment Operating Income
SegmentOperatingIncome
64002000 USD
CY2021Q2 cfx Segment Operating Income
SegmentOperatingIncome
67106000 USD
CY2022Q2 cfx Long Term Debt Reclassed To Current Maturities
LongTermDebtReclassedToCurrentMaturities
421300000 USD

Files In Submission

Name View Source Status
0001420800-22-000008-index-headers.html Edgar Link pending
0001420800-22-000008-index.html Edgar Link pending
0001420800-22-000008.txt Edgar Link pending
0001420800-22-000008-xbrl.zip Edgar Link pending
cfx-20220401.htm Edgar Link pending
cfx-20220401.xsd Edgar Link pending
cfx-20220401_cal.xml Edgar Link unprocessable
cfx-20220401_def.xml Edgar Link unprocessable
cfx-20220401_htm.xml Edgar Link completed
cfx-20220401_lab.xml Edgar Link unprocessable
cfx-20220401_pre.xml Edgar Link unprocessable
exhibit3101ceocertificatio.htm Edgar Link pending
exhibit3102cfocertificatio.htm Edgar Link pending
exhibit3201ceocertificatio.htm Edgar Link pending
exhibit3202cfocertificatio.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending